MWA CONSULTING, INC.
  • Home
  • About MWA
  • Consulting Services
  • Industry News
  • Webinars & Podcasts
  • Consulting Opportunities
  • Contact
  • Privacy Policy
Select Page

FDA Announces Availability of Portal and draft Guidance on Reporting Amount of Listed Drugs and Biological Products

Oct 29, 2021

FDA has announced the new use of a NextGen Portal for reporting the annual amount of listed human and animal drugs and human biological products that an establishment manufactured, prepared, propagated, compounded, or processed (including repacking and relabeling) for...

Are you staying current with FDA regulatory news and compliance trends?

Click here to sign up for MWA’s News You Can Use – it’s fast and free!

Recent Posts

  • FDA Proposed Rule: Quality System Regulation Amendment
  • Center for Devices and Radiological Health (CDRH) Issues 2022-2025 Strategic Priorities
  • Remote Auditing: Three Keys to Success
  • Inspection of Injectable Products for Visible Particulates: Draft Guidance for Industry
  • FDA Announces Availability of Portal and draft Guidance on Reporting Amount of Listed Drugs and Biological Products

Designed by Elegant Themes | Powered by WordPress